GSK shares fall as vaccine concerns overshadow Q3 beat
GSK shares fell as vaccine weakness and doubts about its turnaround overshadowed its third-quarter results.
GSK shares fell as vaccine weakness and doubts about its turnaround overshadowed its third-quarter results.